Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001790340-25-000055
Filing Date
2025-04-21
Accepted
2025-04-21 16:56:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A imrx-2025additionalproxyma.htm DEFA14A 11974
2 definitivematerialsjpeg_pa.jpg GRAPHIC 498239
3 definitivematerialsjpeg_paa.jpg GRAPHIC 318761
  Complete submission text file 0001790340-25-000055.txt   1137789
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40675 | Film No.: 25854057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)